Compare Ritesh Intl. with Similar Stocks
Stock DNA
Commodity Chemicals
INR 46 Cr (Micro Cap)
12.00
42
0.00%
0.26
13.56%
1.55
Total Returns (Price + Dividend) 
Ritesh Intl. for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ritesh International Ltd Downgraded to Sell Amid Technical Weakness and Promoter Stake Reduction
Ritesh International Ltd, a micro-cap player in the Commodity Chemicals sector, has seen its investment rating downgraded from Hold to Sell following a comprehensive reassessment of its quality, valuation, financial trends, and technical indicators. Despite positive quarterly financial results and market-beating returns over the past year, deteriorating technical signals and reduced promoter confidence have weighed heavily on the stock’s outlook.
Read full news article
Ritesh International Ltd Forms Death Cross, Signalling Potential Bearish Trend
Ritesh International Ltd, a micro-cap player in the Commodity Chemicals sector, has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting deteriorating momentum and raising concerns about the stock's medium to long-term outlook.
Read full news article
Ritesh International Q4 FY26: Strong Revenue Growth Masks Margin Pressure
Ritesh International Ltd., a micro-cap player in the commodity chemicals sector, reported net profit of ₹1.05 crores for Q4 FY26, marking a decline of 11.76% quarter-on-quarter but a sharp drop of 48.02% year-on-year. The Punjab-based manufacturer of stearic acid and glycerin posted revenues of ₹48.75 crores, representing a healthy 9.65% sequential growth and 29.59% year-on-year expansion. However, the impressive top-line momentum failed to translate into bottom-line strength as operating margins contracted significantly from 8.19% in Q4 FY25 to just 4.29% in the latest quarter.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
26-May-2026 | Source : BSENewspaper Publication
Results For 31.03.2026
21-May-2026 | Source : BSEResults for the quarter and year ended 31.03.2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 21.05.2026
21-May-2026 | Source : BSEIn continuation to intimation dated 13.05.2026 we wish to inform you that Board of Directors in its meeting held today the 21st day of May 2026 the board meeting commenced at 01:00 P.M. and concluded at 02.00 P.M. inter alia considered and approved the following:
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Non Institution
None
Held by 3 Schemes (0.06%)
Held by 0 FIIs
Rijul Arora (16.6%)
Brisk Securities Ltd (1.84%)
48.89%
Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 9.65% vs 14.77% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is -11.76% vs 12.26% in Dec 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 41.04% vs -36.41% in Sep 2024
Growth in half year ended Sep 2025 is 278.95% vs -82.81% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 29.43% vs -8.44% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 103.88% vs -43.17% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 29.48% vs 54.17% in Mar 2025
YoY Growth in year ended Mar 2026 is 11.52% vs 4,225.00% in Mar 2025






